Intuitive Surgical
30-Second Executive Brief
Executive Assessment
Intuitive Surgical functions as a systemically important institution within Healthcare & Life Sciences, backed by 55% sourcing coverage, with a stable competitive position.
- Maintains 2 mapped relationships across the graph
- 55% sourcing coverage across sourced relationships
- Tracked as systemically important institution within the Healthcare & Life Sciences category
Executive Snapshot
- Strategic Role
- Systemically Important Institution
- Sourcing Coverage
- 55%
- Ecosystem Influence
- Very High
- Strategic Momentum
- Steady
View Methodology →
Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.
Coverage
- Mapped Relationships
- 2
- Technology Domains
- 4
Strategic Implications
- Central node connecting multiple strategic ecosystems
- Directly influences technology and capital flows
- Material relevance to downstream dependency mapping
Top Opportunities
Top Risks
Critical Dependencies
The dominant surgical-robotics company, whose da Vinci platform installed base grew 12% year-over-year to 11,710 systems as of June 30, 2026. Q2 2026 revenue reached $2.89 billion (up 19% year-over-year) with worldwide procedures up approximately 16%; da Vinci 5 placements more than doubled year-over-year to 246 units in the quarter, and Intuitive is rolling out more than 100 updates to the da Vinci 5 platform, including expanded-visibility camera and telepresence features, while raising its 2026 procedure-growth forecast — a scale and momentum that J&J's newly FDA-submitted Ottava system will have to challenge.
Leading Indicators
Hiring and patent filing trends — the underlying numbers Momentum is computed from. Insider filing activity is tracked separately under Sources below.
Additional Intelligence Signals
Patent citation lineage, earnings-call mentions, and federal contract disclosures — automatically collected, not yet visible anywhere else on the site.
Federal contract disclosures
Department of Veterans Affairs — $3,712,707: SERVICE DAVINCI SURGICAL ROBOTS FOR VISN 12 HOSPITALS AND MEDICAL CENTERS.
USAspending.gov · Mar 10, 2020
Department of Veterans Affairs — $2,360,330: DA VINCI XI DUAL CONSOLE SYSTEM
USAspending.gov · Sep 17, 2024
Department of Veterans Affairs — $678,712: BASE +4 DAVINCI CONTRACT
USAspending.gov · Aug 15, 2020
Department of Veterans Affairs — $651,080: PHARMACY IT SERVICE
USAspending.gov · Aug 23, 2020
Department of Defense — $498,000: INTUITIVE DAVINCI ROBOT MAINTENANCE SERVICE
USAspending.gov · Oct 26, 2023
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
2 sources
- MedTech Dive — Intuitive readies 100 updates and improvements for da Vinci 5news
- GlobeNewswire — Intuitive announces second quarter earningscompany
Latest Activity
Insider Filing Activity
Counts filing frequency only — transaction direction/size wasn't parseable from the sampled filings · sourced from SEC EDGAR · as of Sep 7, 2026
Acquisition & Investment Fit
AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.
Relationship Map
The relationships surrounding Intuitive Surgical — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far (last 6 months)
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.
Market Intelligence
UnverifiedCredibly-reported claims — analyst notes, sourcing citing “people familiar with the matter,” deals where the companies involved declined to comment — that haven't been officially confirmed. Kept structurally separate from the sourced evidence above; treat as a lead worth researching further, not an established fact.
Intuitive's installed-base scale is compounding faster than a new entrant can realistically close
34% confidenceIntuitive's da Vinci 5 placements more than doubled year-over-year to 246 units in Q2 2026 alone, pushing the total installed base to 11,710 systems, while J&J's competing Ottava system was only submitted for FDA De Novo classification in January 2026 and has not yet reached commercial launch.
This is InsightNodes' own interpretive read: surgical-robotics adoption is sticky because hospitals train surgeons and build procedural workflows around a specific platform, so Intuitive's widening installed-base lead compounds each quarter Ottava remains pre-launch -- the more relevant competitive question for the next 12-18 months is not whether Ottava can technically match da Vinci 5, but whether J&J can price and distribute aggressively enough to peel away greenfield hospital contracts before Intuitive's lead becomes effectively insurmountable.
InsightNodes analysis of Intuitive Surgical Q2 2026 results · Aug 14, 2026
Intuitive Surgical's Timeline
A sourced, dated history of Intuitive Surgical's key moments — founding to present.
May 2026 · Unveils 100+ da Vinci 5 updates
Intuitive announced more than 100 updates and user-experience improvements for da Vinci 5, including an expanded-visibility camera and telepresence enhancements, with measured US launches beginning in June 2026.
Jul 2026 · Q2 2026: revenue up 19%, procedures up ~16%
Intuitive reported Q2 2026 revenue of $2.89 billion (up 19% year-over-year), with worldwide procedures growing approximately 16% and da Vinci 5 placements more than doubling to 246 units.
How These Connections Evolved
How a relationship changed over time, not just its current state — sourced, dated, and traceable.
Intuitive Surgical ↔ Johnson & Johnson
2015–2020 · Pre-Ottava-platform competitive phase
Intuitive Surgical's competitive position relative to Johnson & Johnson's surgical robotics ambitions predates J&J's Ottava platform's more active late-2020s development push into the space Intuitive has long dominated with its da Vinci system.
Now
Intuitive Surgical's da Vinci platform faces an emerging competitive threat from J&J MedTech's Ottava soft-tissue robotic system, submitted to the FDA for De Novo classification in January 2026.